This inventor holds 2 USPTO granted patents. Top assignees: Sanofi Sa, Sterling Winthrop Inc.. Active years: 1996-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1997
Title: Madhusudhan R Gowravaram: Innovator in Pharmaceutical Chemistry
Introduction
Madhusudhan R Gowravaram is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work has led to the filing of multiple patents, showcasing his innovative approach to solving complex problems in medicine.
Latest Patents
Madhusudhan holds 2 patents related to hydroxamic acid and carboxylic acid derivatives. His latest patents focus on a novel class of hydroxamic and carboxylic acid-based matrix metalloproteinase inhibitor derivatives. These disclosures relate to pharmaceutical compositions containing such compounds and their use in treating matrix metalloproteinase-induced diseases. This innovative work highlights his commitment to advancing therapeutic options in the pharmaceutical industry.
Career Highlights
Throughout his career, Madhusudhan has worked with prominent companies such as Sterling Winthrop Inc. and Sanofi S.A. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.
Collaborations
Madhusudhan has collaborated with notable professionals in his field, including Jeffrey Johnson and Ewell R Cook. These collaborations have further enriched his research and development efforts, leading to innovative solutions in pharmaceutical applications.
Conclusion
Madhusudhan R Gowravaram is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and advancements in medical treatments. His innovative contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
